Department of Traditional Chinese Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Department of Clinical Medicine of Traditional Chinese and Western Medicine, North Sichuan Medical College, Nanchong, Sichuan, China.
BMJ Open. 2022 Mar 25;12(3):e059067. doi: 10.1136/bmjopen-2021-059067.
COVID-19 is a public health emergency of international concern, which is characterised by rapid and widespread transmission, high mortality and complications. Several studies have shown the benefits of tai chi and qigong for recovery after COVID-19; however, no meta-analysis has been reported. Therefore, the purpose of this study is to evaluate the efficacy and safety of tai chi and/or qigong on rehabilitation after COVID-19 through a systematic review and meta-analysis to provide a reference and basis for clinical application.
This study will use the Cochrane Library, PubMed, Web of Science, Embase, China Knowledge Network, China Biomedical Literature Database, Chinese Scientific Journal Database and Wanfang Database. The time period is from the inception of the database to November 2021, with no language restrictions. Searches will be conducted using the subject terms "Taichi","Qigong" and "COVID-19" plus free-text words. Articles will be screened and collected by two reviewers independently. Included studies will be assessed for quality using the Cochrane Risk of Bias Assessment Tool. Statistical analyses will be performed using the Revman V.5.3 software. The primary outcomes include 1-second forced expiratory volume and 1-second forced vital capacity, oxygen saturation, total white cell count and quality of life score. Secondary outcomes include time to remission of major symptoms, incidence of adverse events, clinical cure rate and mortality. Subgroup and sensitivity analyses will also be used to explore and interpret the heterogeneity. This protocol is written based on the guideline of the Preferred Reporting Items for Systematic Reviews and Meta-analyses Protocol.
Ethical approval and consent are unnecessary because no primary data will be collected. The results will be disseminated through peer-reviewed publications.
CRD42021288962.
COVID-19 是国际关注的突发公共卫生事件,其特点是传播迅速广泛、死亡率高、并发症多。多项研究表明,太极拳和气功对 COVID-19 后的康复有益;然而,目前尚无荟萃分析报道。因此,本研究旨在通过系统评价和荟萃分析评估太极拳和气功对 COVID-19 后康复的疗效和安全性,为临床应用提供参考和依据。
本研究将使用 Cochrane 图书馆、PubMed、Web of Science、Embase、中国知识网络、中国生物医学文献数据库、中国科学期刊数据库和万方数据库。时间范围从数据库建立到 2021 年 11 月,无语言限制。检索将使用主题词“太极拳”、“气功”和“COVID-19”加上自由文本词进行。由两名评审员独立筛选和收集文章。使用 Cochrane 偏倚风险评估工具评估纳入研究的质量。统计分析将使用 Revman V.5.3 软件进行。主要结局包括 1 秒用力呼气量和 1 秒用力肺活量、血氧饱和度、总白细胞计数和生活质量评分。次要结局包括主要症状缓解时间、不良事件发生率、临床治愈率和死亡率。还将进行亚组和敏感性分析,以探索和解释异质性。本方案是根据系统评价和荟萃分析报告的首选报告项目指南编写的。
由于不收集原始数据,因此不需要伦理批准和同意。结果将通过同行评审出版物传播。
PROSPERO 注册号:CRD42021288962。